| Phase 4 |
| NCT07154719 |
GLP-1R Actions on Muscle and the Skeleton |
Pennington Biomedical Research Center |
Recruiting |
2026-08-27 |
| NCT07554638 |
Incretin Therapies in Obesity-related HFpEF |
Columbia University |
Recruiting |
2026-08-24 |
| NCT07218445 |
The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in… |
Mayo Clinic |
Recruiting |
2026-08-18 |
| NCT07275697 |
Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study |
Emma Svennberg |
Recruiting |
2026-08-10 |
| NCT06374875 |
Fibrosis Lessens After Metabolic Surgery |
The Cleveland Clinic |
Recruiting |
2026-07-31 |
| NCT07728383 |
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity |
Gila Therapeutics, Inc. |
Recruiting |
2026-07-27 |
| NCT07257484 |
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors |
Weill Medical College of Cornell University |
Recruiting |
2026-07-22 |
| NCT07247084 |
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… |
Eli Lilly and Company |
Recruiting |
2026-07-07 |
| NCT06396416 |
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2 |
Western University, Canada |
Recruiting |
2026-06-29 |
| NCT06864026 |
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… |
Eli Lilly and Company |
Recruiting |
2026-06-11 |
| NCT05919797 |
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion |
Columbia University |
Recruiting |
2026-06-10 |
| NCT05320796 |
The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass |
Prof Urs Zingg |
Recruiting |
2026-06-09 |
| NCT05975580 |
Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain… |
University of California, Irvine |
Recruiting |
2026-06-09 |
| NCT06857942 |
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… |
Eli Lilly and Company |
Recruiting |
2026-06-03 |
| NCT07588438 |
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. |
Las Rías Medical Center |
Recruiting |
2026-05-19 |
| NCT06721507 |
2024 Tirzepatide-Bariatric Surgery |
Marlene Starr |
Recruiting |
2026-05-14 |
| NCT05305313 |
Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia… |
Sir Ganga Ram Hospital |
Recruiting |
2026-04-27 |
| NCT07096908 |
Tirzepatide Use in People With Obesity and Type 1 Diabetes |
Dasman Diabetes Institute |
Recruiting |
2026-04-20 |
| NCT07513168 |
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults |
Asian Institute Of Medical Sciences |
Recruiting |
2026-04-06 |
| NCT05744479 |
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability |
Centre for Addiction and Mental Health |
Recruiting |
2026-03-31 |
| NCT07213466 |
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder |
Mayo Clinic |
Recruiting |
2026-03-11 |
| NCT07401992 |
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis |
Hospital Universitario Dr. Jose E. Gonzalez |
Recruiting |
2026-02-11 |
| NCT05051436 |
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics |
Philip Kern |
Recruiting |
2026-02-03 |
| NCT07163650 |
Evaluating Anti-Obesity Medications 6 Months After Metabolic Surgery |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
Recruiting |
2026-01-27 |
| NCT06132477 |
Impact GLP-1 Agonists Following Bariatric |
University of Missouri-Columbia |
Recruiting |
2026-01-22 |